ArticleScientific reports2022

NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer.

Raksha Bhat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.